Mark M Hassall

Dr. Mark M Hassall

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NCNEIGHBORHOOD consortium
NEIGHBORHOOD consortium
JCJamie E. Craig
Jamie E. Craig
UCUK Biobank Eye and Vision Consortium
UK Biobank Eye and Vision Consortium
XHXikun Han
Xikun Han
AQAyub Qassim
Ayub Qassim
Stuart MacGregorStuart MacGregor
Stuart MacGregor

1 July 2020 in Ophthalmology
Verified
Journal Article
Open access
AQAyub Qassim
Ayub Qassim
ESEmmanuelle Souzeau
Emmanuelle Souzeau
OSOwen M Siggs
Owen M Siggs
MHMark M Hassall
Mark M Hassall
XHXikun Han
Xikun Han
JCJamie E. Craig
Jamie E. Craig
To examine the combined effects of common genetic variants associated with intraocular pressure (IOP) on primary open-angle glaucoma (POAG) phenotype using a polygenic risk score (PRS) stratification. Cross-sectional study. For the primary analysis, we examined the glaucoma phenotype of 2154 POAG patients enrolled in the Australian and New Zealand Registry of Advanced Glaucoma, including patients recruited from the United Kingdom. For replication, we examined an independent cohort of 624 early POAG patients. Using IOP genome-wide association study summary statistics, we developed a PRS derived solely from IOP-associated variants and stratified POAG patients into 3 risk tiers. The lowest and highest quintiles of the score were set as the low- and high-risk groups, respectively, and the other quintiles were set as the intermediate risk group. Clinical glaucoma phenotype including maximum recorded IOP, age at diagnosis, number of family members affected by glaucoma, cup-to-disc ratio, visual field mean deviation, and treatment intensity. A dose-response relationship was found between the IOP PRS and the maximum recorded IOP, with the high genetic risk group having a higher maximum IOP by 1.7 mmHg (standard deviation [SD], 0.62 mmHg) than the low genetic risk group (P = 0.006). Compared with the low genetic risk group, the high genetic risk group had a younger age of diagnosis by 3.7 years (SD, 1.0 years; P < 0.001), more family members affected by 0.46 members (SD, 0.11 members; P < 0.001), and higher rates of incisional surgery (odds ratio, 1.5; 95% confidence interval, 1.1-2.0; P = 0.007). No statistically significant difference was found in mean deviation. We further replicated the maximum IOP, number of family members affected by glaucoma, and treatment intensity (number of medications) results in the early POAG cohort (P ≤ 0.01). The IOP PRS was correlated positively with maximum IOP, disease severity, need for surgery, and number of affected family members. Genes acting via IOP-mediated pathways, when considered in aggregate, have clinically important and reproducible implications for glaucoma patients and their close family members.

1 January 2021 in Ophthalmology
Verified
Journal Article
Closed access
HMHenry Marshall
Henry Marshall
SMSean Mullany
Sean Mullany
AQAyub Qassim
Ayub Qassim
OSOwen M Siggs
Owen M Siggs
MHMark M Hassall
Mark M Hassall
JCJamie E. Craig
Jamie E. Craig

1 August 2019 in Ophthalmology
Verified
Journal Article
Open access
HMHenry N. Marshall
Henry N. Marshall
NANicholas H. Andrew
Nicholas H. Andrew
MHMark M Hassall
Mark M Hassall
AQAyub Qassim
Ayub Qassim
ESEmmanuelle Souzeau
Emmanuelle Souzeau
JCJamie E. Craig
Jamie E. Craig
To investigate which clinical measures influence whether an individual demonstrates earliest glaucomatous structural progression on peripapillary retinal nerve fiber layer (pRNFL) or macular ganglion cell-inner plexiform layer (mGCIPL). Prospective, longitudinal cohort study. Two hundred seventy-one eyes from 207 individuals with statistically significant evidence of glaucomatous progression on OCT Guided Progression Analysis (GPA) software were drawn from a total of 1271 eyes from 686 individuals categorized as glaucoma suspect or having early manifest glaucoma undergoing glaucoma surveillance. Individuals demonstrating earliest evidence of longitudinal progression on mGCIPL GPA event analysis were compared with individuals demonstrating evidence of earliest longitudinal progression on pRNFL GPA event analysis. Correlation of OCT event change analysis with intraocular pressure (IOP), clinical variables, and baseline thickness of the pRNFL and mGCIPL. Intraocular pressure, baseline pRNFL thickness, baseline mGCIPL thickness, and systemic hypertension were associated with location of first progression. Eyes demonstrating earliest longitudinal progression on mGCIPL had significantly lower maximum-recorded pretreatment IOP (mean difference, 3.90 mmHg; 95% confidence interval [CI], 2.37-5.43 mmHg; P < 0.001). The interval between progression on pRNFL and progression on mGCIPL increased by 12.4 months for every 5-mmHg increase in IOP (95% CI, 10.32-15.72 months). Eyes demonstrating earliest longitudinal progression on mGCIPL showed significantly lower baseline average pRNFL thickness than eyes progressing on pRNFL first (mean difference, 7.07 μm; 95% CI, 4.38-9.77 μm; P < 0.001). Eyes progressing first on mGCIPL parameters were 3.03 times more likely to demonstrate a new paracentral field defect than eyes progressing first on pRNFL parameters (odds ratio, 3.03; 95% CI, 1.26-7.28; P = 0.01). Clinical features, particularly pretreatment IOP, influence whether structural glaucoma progression is detected earlier with mGCIPL or pRNFL imaging. These data support the usefulness of mGCIPL imaging in addition to pRNFL analysis for detection of glaucoma progression, particularly in patients with normal IOP.

6 September 2019 in Human Molecular Genetics
Verified
Journal Article
Closed access
XHXikun Han
Xikun Han
AQAyub Qassim
Ayub Qassim
JAJiyuan An
Jiyuan An
HMHenry Marshall
Henry Marshall
TZTiger Zhou
Tiger Zhou
SMStuart MacGregor
Stuart MacGregor
Optic nerve head morphology is affected by several retinal diseases. We measured the vertical optic disc diameter (DD) of the UK Biobank (UKBB) cohort (N = 67 040) and performed the largest genome-wide association study (GWAS) of DD to date. We identified 81 loci (66 novel) for vertical DD. We then replicated the novel loci in International Glaucoma Genetic Consortium (IGGC, N = 22 504) and European Prospective Investigation into Cancer–Norfolk (N = 6005); in general the concordance in effect sizes was very high (correlation in effect size estimates 0.90): 44 of the 66 novel loci were significant at P < 0.05, with 19 remaining significant after Bonferroni correction. We identified another 26 novel loci in the meta-analysis of UKBB and IGGC data. Gene-based analyses identified an additional 57 genes. Human ocular tissue gene expression analysis showed that most of the identified genes are enriched in optic nerve head tissue. Some of the identified loci exhibited pleiotropic effects with vertical cup-to-disc ratio, intraocular pressure, glaucoma and myopia. These results can enhance our understanding of the genetics of optic disc morphology and shed light on the genetic findings for other ophthalmic disorders such as glaucoma and other optic nerve diseases.

10 April 2023 in Ophthalmology
Verified
Journal Article
Closed access
HMHenry N. Marshall
Henry N. Marshall
SMSean Mullany
Sean Mullany
XHXikun Han
Xikun Han
AQAyub Qassim
Ayub Qassim
WHWeixiong He
Weixiong He
JCJamie E. Craig
Jamie E. Craig